Search results
The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar...
Zacks via Yahoo Finance· 1 day agoGSK's Study Data: GSK plc announced its two late-stage studies on pipeline candidate depemokimab in...
GSK Sees Positive Results for Severe Asthma Treatment Depemokimab
Market Watch· 5 days agoBy Najat Kantouar GSK said that it had positive results from phase III trials of depemokimab, aimed at assessing the drug's efficacy and safety in adults and...
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
Zacks via Yahoo Finance· 2 days agoGSK’s Study Data: GSK plc GSK announced its two late-stage studies on pipeline candidate depemokimab...
Signs and Symptoms of Esophagitis
Health via Yahoo News· 6 days agoSeek immediate medical attention if you experience any of the following: Severe chest pain that lasts more than a few minutes Inability to swallow or...
Tezepelumab Shows Potential for COPD, Negative Trial Notwithstanding
MedPage Today· 4 days agoAsthma drug may benefit patients with blood eosinophil counts indicative of type 2 inflammation
Johnson & Johnson plans $850M Proteologix acquisition
NJBIZ· 5 days agoA May 16 press release announced the all-cash deal. The New Brunswick-based pharma giant said the move will add depth to its dermatology portfolio by boosting its position to address atopic ...
Why Do Racial Disparities Exist In Asthma Risk and Diagnosis?
Health.com· 4 days agoThe United States has spent decades cleaning up air pollution. In 1970, the Clean Air Act (CAA)...
NEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIRE® TO HELP PATIENTS LIVING WITH COPD
Morningstar· 6 days agoAmgen (NASDAQ:AMGN) and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating Tezspire® (tezepelumab-ekko) in people with moderate to very severe ...
Navigating Asthma and Allergies in Children
Los Angeles Times· 4 days agoAs a pediatrician with MemorialCare Medical Group, I understand the challenges parents face in managing asthma and allergies in their children. May is...
Regeneron faces new biosimilar threats; an AI biotech lays off staff
BioPharma Dive via Yahoo Finance· 3 days agoTreatment with the drug, an antibody called depemokimab, significantly reduced the annualized rate...
